Valuation Alfresa Holdings Corporation

Stocks

Market Closed - Japan Exchange 04:30:00 18/09/26 pm AEST			5-day change	1st Jan Change
2,353.00 ^JPY	-1.24%		+0.71%	-3.21%

01/07	Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation	CI
22/06	Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	343,826	343,217	415,318	383,847	459,384	412,748	-	-
Change	-	-0.18%	21.01%	-7.58%	19.68%	-10.15%	-	-
Enterprise Value (EV)	168,429	186,950	236,499	242,307	301,938	412,748	412,748	412,748
Change	-	11%	26.5%	2.46%	24.61%	36.7%	0%	0%
P/E	11.1x	13.3x	14.4x	14.3x	11x	17.8x	15x	15.6x
PBR	0.73x	0.7x	0.87x	0.8x	0.91x	0.82x	0.79x	0.79x
PEG	-	-0.8x	0.7x	-3.34x	0.2x	-0.4x	0.8x	-3.83x
Capitalization / Revenue	0.13x	0.13x	0.15x	0.13x	0.15x	0.13x	0.13x	0.12x
EV / Revenue	0x	0x	0x	0x	0x	0.13x	0.13x	0.12x
EV / EBITDA	0x	0x	0x	0x	0x	7.99x	7.9x	7.86x
EV / EBIT	0x	0x	0x	0x	0x	12x	11.2x	10.8x
EV / FCF	0x	-0x	0x	-0x	0x	19.7x	25.2x	34.4x
FCF Yield	11.3%	-2.17%	17.4%	-4.12%	6.5%	5.09%	3.96%	2.91%
Dividend per Share ²	54	57	70	63	68	71	79.67	85
Rate of return	3.18%	3.36%	3.15%	2.98%	2.69%	3.02%	3.39%	3.61%
EPS ²	153.6	127.4	154.1	147.5	229.6	132.4	157	150.6
Distribution rate	35.2%	44.7%	45.4%	42.7%	29.6%	53.6%	50.8%	56.5%
Net sales ¹	2,585,643	2,696,069	2,858,500	2,961,051	3,104,064	3,193,819	3,288,778	3,340,075
EBITDA ¹	41,915	43,450	51,974	58,607	51,212	51,628	52,221	52,514
EBIT ¹	29,091	30,148	38,460	38,080	36,164	34,398	36,942	38,069
Net income ¹	32,182	25,786	29,558	27,389	41,746	23,414	27,149	26,886
Net Debt	-175,397	-156,267	-178,819	-141,540	-157,446	-	-	-
Reference price ²	1,699.00	1,696.00	2,222.50	2,111.50	2,528.00	2,353.00	2,353.00	2,353.00
Nbr of stocks (in thousands)	202,370	202,369	186,870	181,789	181,719	175,413	-	-
Announcement Date	16/5/22	15/5/23	14/5/24	15/5/25	15/5/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALFRESA HOLDINGS CORPORATION	17.78x	-	-	3.02%	2.62B
ABBOTT LABORATORIES	29.38x	4.05x	15.66x	2.48%	179B
MEDTRONIC PLC	19.2x	3.51x	12.56x	3.1%	116B
CENCORA, INC.	17.22x	0.2x	12.61x	0.76%	60B
BECTON, DICKINSON AND COMPANY	35.27x	3.41x	11.68x	2.14%	49.85B
HOYA CORPORATION	27.56x	6.78x	17.54x	1.45%	48.05B
DEXCOM, INC.	35.89x	6.31x	19.82x	-.--%	33.79B
MEDLINE INC.	44.45x	1.29x	11.95x	0.21%	30.21B
WEST PHARMACEUTICAL SERVICES, INC.	43.27x	7.59x	27.23x	0.24%	26.12B
SARTORIUS STEDIM BIOTECH	52.64x	7.06x	22.71x	0.4%	22.98B
Average	32.27x	4.47x	16.86x	1.38%	56.91B
Weighted average by Cap.	29.09x	3.98x	15.38x	1.86%